Bhabita Mayer

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 787 citations · Full text

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 574 citations · Full text

Thrombopoiesis, Thrombosis, Venous Thrombosis +12

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

Ian Pavord, Pascal Chanez, Gerard J. Criner et al. · New England Journal of Medicine · 2017 · 563 citations · Full text

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Héctor Ortega, Steven W. Yancey, Bhabita Mayer et al. · The Lancet Respiratory Medicine · 2016 · 545 citations

Asthma, Severe Eosinophilic Asthma, Allergy +8

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

James B. Bussel, Drew Provan, Tahir Shamsi et al. · The Lancet · 2009 · 537 citations

Platelet Counts, Thrombosis, Thrombopoiesis +8